Neil Cartwright, Green Ark
Organigram agrees C$561m Aurora deal, but Curaleaf's hostile bid has not yet lapsed
Organigram and Aurora announced a C$7.80-per-share acquisition on 3 November 2026, subject to shareholder, regulatory and court approvals. What it means for European medical supply turns on EU-GMP sites and the German import…
